and the CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - Colhoun, HM; Betteridge, DJ; Durrington, PN (Lancet, 2004)